The Break COVID Now Summit

8 April 2022 | 12:00 CEST

World leaders commit US$ 4.8 billion to help Break COVID Now

  • 2022 Break COVID Now Summit co-hosted by Gavi, alongside Germany (G7 President), Ghana, Indonesia (G20 President), and Senegal (African Union chair) reaffirms support for COVAX and global solidarity in fighting the COVID-19 pandemic.

Read more


Alongside Germany (which holds the G7 presidency in 2022), Indonesia (holding the G20 presidency), Senegal (whose President is chairing the African Union this year) and Ghana, Gavi co-hosted a leader-level meeting aimed at helping raise at least US$ 3.8 billion from donors as part of a wider US$ 5.2 billion package of support for lower-income countries supported by the Gavi COVAX Advance Market Commitment (Gavi COVAX AMC).

The virtual event – “2022 Gavi COVAX Advance Market Commitment (Gavi COVAX AMC) Summit: Break COVID Now” – was co-chaired by Svenja Schulze, German Minister for Economic Cooperation and Development and José Manuel Barroso, Chair of the Gavi Board.

In 2022, COVAX will be focused on building on the foundation in place, serving as an adaptable and flexible mechanism to support lower-income countries’ national COVID-19 vaccine objectives, and contributing to the global effort to break COVID. 



Svenja Schulze
Minister for Economic Cooperation and Development, Germany


José Manuel Barroso


José Manuel Barroso
Chair of the Gavi Board

The Gavi COVAX AMC Investment Opportunity

Last updated on 31 January 2022

View full screen

DOWNLOAD: English | French | Chinese | Japanese | German | Spanish | Arabic | Italian

Break COVID Now Summit Priorities

Click here to see the priorities for the summit and how COVAX will provide AMC countries with flexible and adaptable mechanisms to help them Break COVID now.

Click here to see how Gavi’s Innovative Financial Instruments can help donors and partners contribute to the US $5.2bn in urgent financial support for COVAX.

Germany support for Gavi

As a Gavi donor since 2006, Germany contributes to Gavi through direct contributions. The 2013 Vaccine Summit in Abu Dhabi marked Germany’s first multi-year commitment to Gavi with a pledge of EUR 90 million over 2013-2015, and as patron of Gavi’s replenishment conference in Berlin in January 2015, Germany pledged EUR 600 million to Gavi over the 2016–2020 strategic period

In January 2020, as Gavi met in Davos to celebrate its 20th anniversary, Chancellor Merkel was the first world leader to pledge for Gavi’s 2021-2025 strategic period, announcing Germany’s commitment of another EUR 600 million for the five years.

Germany’s total cash contribution of EUR 1,03 billion to COVAX includes EUR 800m towards the Gavi COVAX AMC for vaccine purchase, EUR 180m towards vaccine logistics (UNICEF) via COVAX/Gavi and EUR 50m for the Humanitarian Buffer. As the Gavi COVAX AMC’s second biggest donor with a EUR 1.03 billion overall cash contribution across 2020-2021, Germany is also the largest EU dose-donor with a commitment to donate 175m doses by 2022 (of which approx. 100m have already been donated to COVAX).

Timeline of Germany support for Gavi

  • 2006: Germany becomes a Gavi donor.
  • 2013: EUR 90 million pledged by Germany to Gavi over 2013-2015 at the 2013 Vaccine Summit.
  • 2015: As patron of Gavi’s replenishment conference in Berlin in January 2015, Germany pledges EUR 600 million to Gavi over the 2016–2020 strategic period.
  • 2020: Chancellor Merkel announces Germany’s commitment of another EUR 600 million for Gavi’s 2021-2025 strategic period.
  • 2020: Germany confirms a commitment of EUR 100 million towards the Gavi COVAX AMC.
  • 2021: An additional EUR 980 million is pledged by Germany to COVAX, which placed Germany firmly among Gavi’s top donors.
  • 2021: Germany increases its dose-sharing contribution to 175 million doses by the end of 2022, of which more than 100 million have been donated to date.
  • 2021: First delivery of German-donated COVID vaccines to COVAX land in Mauritania.

The Gavi COVAX Advance Market Commitment (AMC) is an innovative financial mechanism that ensures the world’s poorest countries will get access to COVID-19 vaccines, regardless of their ability to pay.

Learn more

Last updated: 3 May 2022

Subscribe to our newsletter